BioSpace News Archive

Kemin Industrie has released a novel study on the interaction of non-starch polysaccharides from wheat with the addition of feed enzymes, such as KEMZYME®.

Stephen Sofen, Ph.D. to head technical operations and Susan Stewart, J.D. to lead regulatory affairs and quality

Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, today announced that medical device industry veteran Donald J. Zurbay has joined its board of directors.

PharmaCyte Biotech, Inc. (OTCQB: PMCB) today announced that it has filed a U.S. patent application with the United States Patent and Trademark Office (USPTO) to protect its therapy to treat cancerous tumors

Policy supports mandates on opioid prescribing and continuing education

Macrolide Pharmaceuticals announced it has been granted a CARB-X award of up to $6.8M to support the development of a novel fully synthetic, orally available macrolide antibiotic with Gram-negative activity, with the aim of treating serious infections including drug-resistant complicated urinary tract infections (cUTI).

- Image quality and ease of use set new standard for digital pathology, with the goal of empowering faster, better care for patients - Able to produce high-quality images from a wide variety of histology samples, special stains, bone marrow and cytology and frozen tissue sections

Teva Pharmaceutical Industries Limited announced the launch of a generic version of Lialda®1 (mesalamine) delayed-release tablets, 1.2 g, in the U.S.

Invitae Corporation announced that it has commenced an underwritten public offering of $50.0 million of shares of its common stock, before deducting underwriting discounts and commissions and other offering expenses.

Apollo Medical Holdings Inc. announced that it will be presenting at Needham & Company’s 17th Annual Healthcare Conference on March 28, 2018. The Company will also be hosting investor meetings.